These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2885865)

  • 21. Cholinergic rebound in neuroleptic withdrawal syndromes.
    Lieberman J
    J Clin Psychiatry; 1981 Apr; 42(4):179. PubMed ID: 6110656
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
    Ozone M; Yagi T; Itoh H; Tamura Y; Inoue Y; Uchimura N; Sasaki M; Shimizu T; Terzano MG; Parrino L
    Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine use as a model of acute and chronic insomnia.
    Bonnet MH; Arand DL
    Sleep; 1992 Dec; 15(6):526-36. PubMed ID: 1475567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cerebral seizures in neuroleptic therapy].
    Bartels M; Heimann H
    Psychiatr Prax; 1985 Nov; 12(6):189-93. PubMed ID: 2867570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.
    Mouret J; Ruel D; Maillard F; Bianchi M
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():47-55. PubMed ID: 2201730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism.
    Thaker GK; Wagman AM; Kirkpatrick B; Tamminga CA
    Biol Psychiatry; 1989 Jan; 25(1):75-86. PubMed ID: 2563233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonazepam: sleep laboratory study of efficacy and withdrawal.
    Kales A; Manfredi RL; Vgontzas AN; Baldassano CF; Kostakos K; Kales JD
    J Clin Psychopharmacol; 1991 Jun; 11(3):189-93. PubMed ID: 2066457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
    Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H
    Encephale; 1995; 21(3):209-15. PubMed ID: 7649071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep in schizophrenia patients and the effects of antipsychotic drugs.
    Monti JM; Monti D
    Sleep Med Rev; 2004 Apr; 8(2):133-48. PubMed ID: 15033152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
    Röther J; Jakob J; Bender HJ; Hewer W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):455-7. PubMed ID: 8562725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insomnia related to biperiden withdrawal in two schizophrenic patients.
    Hirose S
    Int Clin Psychopharmacol; 2000 Nov; 15(6):357-9. PubMed ID: 11110012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
    Luchins DJ; Freed WJ; Wyatt RJ
    Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insomnia among addicts during supervised withdrawal from opiates: a comparison of oral methadone and electrostimulation.
    Gossop M; Bradley B
    Drug Alcohol Depend; 1984 Mar; 13(2):191-8. PubMed ID: 6609807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lorazepam: effects on sleep and withdrawal phenomena.
    Kales A; Bixler EO; Soldatos CR; Jacoby JA; Kales JD
    Pharmacology; 1986; 32(3):121-30. PubMed ID: 3960963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rebound insomnia and rebound anxiety: a review.
    Kales A; Soldatos CR; Bixler EO; Kales JD
    Pharmacology; 1983; 26(3):121-37. PubMed ID: 6132413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines.
    Kales A; Manfredi RL; Vgontzas AN; Bixler EO; Vela-Bueno A; Fee EC
    Clin Pharmacol Ther; 1991 Apr; 49(4):468-76. PubMed ID: 2015735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics?
    Hohagen F; Montero RF; Weiss E; Lis S; Schönbrunn E; Dressing H; Riemann D; Berger M
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(2):65-72. PubMed ID: 7948056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Does a rebound insomnia following benzodiazepine administration exist?].
    Ladewig D
    Dtsch Med Wochenschr; 1980 Oct; 105(43):1483-4. PubMed ID: 7428651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.